APR 04

Biologics Facility Design & Pharmaceutical Regulatory Aspects - 2017


Conference CFP




  04 Apr 2017 through 04 Apr 2017

CFP Deadline:

  04 Apr 2017


  Online Event

Website URL:


Sponsoring organization:



  Medicine & Health > Public-Health

Event description:

Overview: This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them. Why should you Attend: The attendee will learn what is important in facility design from the FDA and regulatory standpoint. The attendee will understand what FDA looks for during a facility inspection. The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build. The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns. Areas Covered in the Session: Best design practices for Pharma facilities Best design practices for biologics facilities Regulatory compliance for Pharma and biologics facilities design Flow patterns and cross contamination controls Who Will Benefit: Compliance Manager Facility Manager Validation Manager Regulatory Manager Design Team/Architects Speaker Profile: John R. Godshalk currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy. Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com

Posting date:

01 March 2017
views | 1 subscribers | Be the first to rate this event


Not-featured (How do I make my event featured?)